Descrição
Germany's Bayer has aborted a large late-stage trial testing a new anti-clotting drug for lack of efficacy, dealing a fresh blow to the embattled drugmaker and throwing its most promising medium-term development project in doubt. It said in a statement late on Sunday that experimental anticoagulant asundexian, which it had hoped would generate annual sales of more than 5 billion
Digitrio promises to deliver Faster, Better SEO using the Pareto Principle, Business News - AsiaOne
Pfizer/BioNTech Covid-19 vaccine shows 90.7% efficacy in trial in children, World News - AsiaOne
Blood Thinners Recalled Over Cancer-Causing Impurity
WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale, Business News - AsiaOne
Bayer Stops Blood Thinner Drug Trial Due To Lack Of Effect, In Major Setback • GABI
Moderna recalls thousands of Covid-19 vaccine doses in Europe, World News - AsiaOne
Asteroid's sudden flyby shows blind spot in planetary threat detection, World News - AsiaOne
WhatsApp working on option to react to a message with any emoji, Digital News - AsiaOne
New Zealand PM disagrees with Biden, says Xi Jinping not a 'dictator', World News - AsiaOne
Woman falls sick after taking ivermectin, HSA probing illegal distribution of drug, Singapore News - AsiaOne
Duchess Meghan sought advice from senior royals before writing letter to father, World News - AsiaOne
Asylum seekers in Italy told to pay to avoid detention, World News - AsiaOne
Bayer stops blood thinner drug trial for lack of effect in major setback
de
por adulto (o preço varia de acordo com o tamanho do grupo)
:quality(70)/d1hfln2sfez66z.cloudfront.net/03-02-2022/t_47f6ec1dcf7b462294c7d66e9e14ef87_name_MicrosoftTeams_image__17_.png)
